Keyphrases
Type 2 Diabetes Mellitus (T2DM)
100%
Randomized Clinical Trial
100%
Confidence Interval
58%
Dietary Control
56%
Exercise-induced
50%
Resuscitation Fluid
50%
Usual Care
50%
Feasibility Trial
50%
Dietary Weight Loss
50%
β-cell Function
50%
Septic Shock Patients
50%
Living with
50%
Caloric Restriction
50%
Fat Loss
50%
Fat Mass
31%
Exercise Dose
20%
New-onset Type 2 Diabetes
20%
Volume of Fluid
16%
Intensive Care Unit
16%
Septic Shock
16%
Dose Effect
14%
Randomized Trial
14%
Tissue Volume
13%
Fat-free Mass
13%
Visceral Adipose Tissue
13%
Exercise Volume
10%
Adverse Events
10%
Group Events
10%
Exercise Intervention
10%
Secretory Activity
10%
Serious Adverse Events
10%
Diet Exercise
9%
Fat Mass Percentage
9%
Hodges-Lehmann
8%
All-cause Mortality
8%
Ischemic Events
8%
Health-related Quality of Life
8%
Restrictive Fluid
8%
Mechanical Ventilation
8%
Improved Outcomes
8%
Injury Events
8%
Fluid Administration
8%
Protocol Compliance
8%
Acute Kidney Injury
8%
Randomised Feasibility Trial
8%
Intensive Care Unit Admission
8%
Median Difference
8%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Randomized Clinical Trial
100%
Cell Function
50%
Septic Shock
50%
Beta Cell
50%
Fluid Resuscitation
50%
Caloric Restriction
50%
Minimal Effective Dose
42%
Intensive Care Unit
25%
Adipose Tissue
21%
Adverse Event
20%
Artificial Respiration
8%
All Cause Mortality
8%
Quality of Life
8%
Acute Kidney Injury
8%
Dose Response
7%
